GAFFX
Price
$72.65
Change
-$0.09 (-0.12%)
Updated
May 9 closing price
Net Assets
285.87B
TPLGX
Price
$68.42
Change
-$0.26 (-0.38%)
Updated
May 9 closing price
Net Assets
2.69B
Ad is loading...

GAFFX vs TPLGX

Header iconGAFFX vs TPLGX Comparison
Open Charts GAFFX vs TPLGXBanner chart's image
American Funds Growth Fund of Amer F3
Price$72.65
Change-$0.09 (-0.12%)
VolumeN/A
Net Assets285.87B
T. Rowe Price Instl Large Cap Core Gr
Price$68.42
Change-$0.26 (-0.38%)
VolumeN/A
Net Assets2.69B
GAFFX vs TPLGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GAFFX vs. TPLGX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GAFFX is a StrongBuy and TPLGX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
GAFFX has more cash in the bank: 286B vs. TPLGX (2.69B). GAFFX pays higher dividends than TPLGX: GAFFX (0.70) vs TPLGX (0.03). GAFFX was incepted earlier than TPLGX: GAFFX (8 years) vs TPLGX (22 years). TPLGX (0.56) is less costly to investors than GAFFX (0.30). GAFFX is a more actively managed with annual turnover of: 25.00 vs. TPLGX (15.50). GAFFX (1000000) and TPLGX (1000000) have matching initial minimum investment requirements. GAFFX annual gain was more profitable for investors over the last year : 3.51 vs. TPLGX (-0.18). GAFFX return over 5 years is better than : 46.03 vs. TPLGX (38.24).
GAFFXTPLGXGAFFX / TPLGX
Total Expense Ratio0.300.5654%
Annual Report Gross Expense Ratio0.300.5654%
Fund Existence8 years22 years-
Gain YTD-2.444-4.80951%
Front LoadN/AN/A-
Min. Initial Investment10000001000000100%
Min. Initial Investment IRAN/AN/A-
Net Assets286B2.69B10,624%
Annual Yield % from dividends0.700.032,398%
Returns for 1 year3.51-0.18-1,982%
Returns for 3 years34.0840.0785%
Returns for 5 years46.0338.24120%
Returns for 10 yearsN/A160.27-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
PENN15.640.35
+2.29%
PENN Entertainment
CRL138.79-2.57
-1.82%
Charles River Laboratories International
ACRS1.26-0.05
-3.82%
Aclaris Therapeutics